Acrometa Group Announces Binding JV with Wan Qian for AI-Powered Global Trade Platform

Key Highlights

• Acrometa Group Limited has entered into a binding term sheet to form a joint venture with Ms Wan Qian, aiming to develop and operate an AI-powered global trade operating system.
• The joint venture will be conducted through Acrometa Lifestyle Pte. Ltd, which will transition from a dormant entity to an active player in wholesale trade, focusing on advanced AI-driven e-commerce solutions.
• The new business model marks a strategic shift from passive online marketplaces to an intelligent, automated platform capable of sourcing, executing, and managing cross-border procurement, including payments, logistics, and customs.

Details of the Joint Venture

• Date of JV Term Sheet: 29 November 2025
• Parties: Acrometa Group Limited and Ms Wan Qian (WQ), a Chinese national and experienced executive in software and technology sectors.
• Target Company: Acrometa Lifestyle Pte. Ltd (UEN No. 202440510C), currently a 100% subsidiary of Acrometa Group, with a paid-up capital of S\$10,000 and dormant status.
• Capital Injection: The paid-up capital will be increased by S\$500,000, with Acrometa injecting S\$200,000 and WQ providing S\$300,000. The post-injection shareholding structure will be 51% for Acrometa and 49% for WQ.
• Initial Funding: Acrometa will inject S\$100,000 and WQ S\$150,000 within three days of the term sheet signing, with the balance to be paid within three months or upon signing of Definitive Agreements, whichever is later.

Governance and Management

• The board of the Target Company will comprise one representative from Acrometa (Mr Lawrence Toh, who will serve as Chairman) and one from WQ.
• WQ will act as General Manager, overseeing daily operations and tasked with commencing revenue-generating activities within three months of executing the Definitive Agreements.
• All non-ordinary business matters will require board approval, and possibly Acrometa’s Board approval where necessary.

Business Model and Strategic Importance

The joint venture aims to revolutionize global trade by leveraging artificial intelligence to autonomously identify procurement opportunities worldwide and manage the entire trade execution process. This includes integrating payment, logistics, and customs solutions in a seamless platform, positioning the new entity at the leading edge of AI-driven commerce.

The initiative is expected to transition Acrometa into new growth areas beyond its current core operations, potentially unlocking significant value for shareholders should the platform achieve commercial traction.

Financial Impact

• The investment in the joint venture will be funded from Acrometa’s internal resources.
• Management expects no material impact on the company’s net tangible assets per share or earnings per share for the financial year ending 30 September 2026.
• Should material impacts arise, the company will make further announcements to ensure market transparency.

Next Steps and Shareholder Considerations

• The parties have committed to negotiating and signing definitive agreements within 30 days of the term sheet date. These agreements will formalize the JV structure and business plan.
• Acrometa will provide ongoing disclosures on the JV’s progress, including compliance with SGX Catalist Rules and any material developments.
• Shareholders should note that this JV represents a strategic expansion into the AI and e-commerce sector, which could be highly price-sensitive if successful.
• No directors, substantial shareholders, or their associates currently have any direct or indirect interest in the JV, aside from their existing shareholdings in Acrometa.
• A copy of the JV term sheet is available for inspection at Acrometa’s registered office for three months from the announcement.

Cautionary Note for Investors

Shareholders and potential investors are strongly encouraged to monitor further announcements regarding the JV. As with all early-stage ventures in new technology sectors, there are execution and market risks. Investors should exercise caution and, if in doubt, consult their professional advisers before making investment decisions related to Acrometa shares.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. While every effort has been made to ensure accuracy, investors should refer to official disclosures for the most reliable and up-to-date information. The author and publisher accept no liability for any losses arising from reliance on this article.

View AcroMeta Historical chart here